MedPath

Comparison of two different peeling agents in hyperpigmentation of face

Phase 2
Conditions
Health Condition 1: L819- Disorder of pigmentation, unspecified
Registration Number
CTRI/2023/10/058809
Lead Sponsor
saveetha hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients more than 18 years of age consenting to be a part of the study

2.Patients with-

Melasma

Seborrheic melanosis

Frictional melanosis

Pigmented allergic contact dermatitis

Phototanning

Freckles

Acanthosis nigricans

Post inflammatory hyperpigmentation

3.Patients who have not received any medical treatment for the above mentioned conditions

Exclusion Criteria

1.Patients not willing to be a part of the study

2.Patients less than 18 years of age

3.Pregnancy

4.Lactation

5.Patients taking oral contraceptive pills/isotretinoin

6.Patients with a history of Herpes

7.Patients with history of keloids/hypertrophic scars

8.Patients with concomitant systemic/skin disease

9.Patients not consenting for therapy

10.Patients diagnosed with conditions other than acquired non nevoid facial melanosis

11.Patients who have taken treatment previously

12.Patients with unrealistic expectations

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath